Cargando…

Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study

OBJECTIVE: Nonconvulsive status epilepticus (NCSE) is misdiagnosed in >50% of cases in the emergency department. Computed tomographic perfusion (CTP) has been implemented in the hyperacute setting to detect seizure‐induced hyperperfusion. However, the diagnostic value of CTP is limited by the lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Romoli, Michele, Merli, Elena, Galluzzo, Simone, Muccioli, Lorenzo, Testoni, Stefania, Zaniboni, Anna, Contardi, Sara, Simonetti, Luigi, Tinuper, Paolo, Zini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796764/
https://www.ncbi.nlm.nih.gov/pubmed/35793391
http://dx.doi.org/10.1111/epi.17359
_version_ 1784860560983064576
author Romoli, Michele
Merli, Elena
Galluzzo, Simone
Muccioli, Lorenzo
Testoni, Stefania
Zaniboni, Anna
Contardi, Sara
Simonetti, Luigi
Tinuper, Paolo
Zini, Andrea
author_facet Romoli, Michele
Merli, Elena
Galluzzo, Simone
Muccioli, Lorenzo
Testoni, Stefania
Zaniboni, Anna
Contardi, Sara
Simonetti, Luigi
Tinuper, Paolo
Zini, Andrea
author_sort Romoli, Michele
collection PubMed
description OBJECTIVE: Nonconvulsive status epilepticus (NCSE) is misdiagnosed in >50% of cases in the emergency department. Computed tomographic perfusion (CTP) has been implemented in the hyperacute setting to detect seizure‐induced hyperperfusion. However, the diagnostic value of CTP is limited by the lack of thresholds for hyperperfusion and high interrater variability. This pilot case–control study aims at identifying the diagnostic value of reverse Tmax (rTmax) in differentiating NCSE from acute ischemic stroke in the hyperacute setting. METHODS: We enrolled patients with NCSE (Salzburg criteria‐based diagnosis) and stroke cases 1:1 matched for clinical features and time of presentation. CTP standard maps (mean transit time [MTT]–cerebral blood volume–cerebral blood flow [CBF]) and rTmax maps were elaborated and rated by two experts in CTP blinded to the final diagnosis. Hyperperfusion was adjudicated for standard CTP maps as an increase in CBF and a decrease in MTT, and for rTmax as the presence of a black area on 3‐, 2‐, and 1‐s threshold maps. Cronbach alpha was used for interrater agreement; receiver operating curve analysis was run to measure accuracy with area under the curve. RESULTS: Overall, 34 patients were included (17 NCSE, 17 stroke; time from onset to imaging = 2 h for both groups). People with NCSE were older and more frequently had a history of epilepsy. NCSE patients had hyperperfusion on rTmax maps in 11 of 17 cases versus zero of 17 in stroke. Intra‐ and interrater reliability was higher for rTmax than for standard CTP maps (κ = 1 vs. κ = .6). rTmax was 82% (95%CI = 67–97%) accurate in predicting NCSE versus stroke in the hyperacute setting. Agreement between neuroimaging and electroencephalography (EEG) was limited at a hemispheric level for standard CTP maps, whereas rTMax had agreement with EEG largely reaching the sublobar level. SIGNIFICANCE: rTmax mapping might represent a reliable tool to spot NCSE‐induced hyperperfusion with a threshold‐based reproducible approach. Further studies are needed for validation and implementation in the differential diagnosis of focal neurological deficit in the hyperacute setting.
format Online
Article
Text
id pubmed-9796764
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97967642023-01-04 Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study Romoli, Michele Merli, Elena Galluzzo, Simone Muccioli, Lorenzo Testoni, Stefania Zaniboni, Anna Contardi, Sara Simonetti, Luigi Tinuper, Paolo Zini, Andrea Epilepsia Research Article OBJECTIVE: Nonconvulsive status epilepticus (NCSE) is misdiagnosed in >50% of cases in the emergency department. Computed tomographic perfusion (CTP) has been implemented in the hyperacute setting to detect seizure‐induced hyperperfusion. However, the diagnostic value of CTP is limited by the lack of thresholds for hyperperfusion and high interrater variability. This pilot case–control study aims at identifying the diagnostic value of reverse Tmax (rTmax) in differentiating NCSE from acute ischemic stroke in the hyperacute setting. METHODS: We enrolled patients with NCSE (Salzburg criteria‐based diagnosis) and stroke cases 1:1 matched for clinical features and time of presentation. CTP standard maps (mean transit time [MTT]–cerebral blood volume–cerebral blood flow [CBF]) and rTmax maps were elaborated and rated by two experts in CTP blinded to the final diagnosis. Hyperperfusion was adjudicated for standard CTP maps as an increase in CBF and a decrease in MTT, and for rTmax as the presence of a black area on 3‐, 2‐, and 1‐s threshold maps. Cronbach alpha was used for interrater agreement; receiver operating curve analysis was run to measure accuracy with area under the curve. RESULTS: Overall, 34 patients were included (17 NCSE, 17 stroke; time from onset to imaging = 2 h for both groups). People with NCSE were older and more frequently had a history of epilepsy. NCSE patients had hyperperfusion on rTmax maps in 11 of 17 cases versus zero of 17 in stroke. Intra‐ and interrater reliability was higher for rTmax than for standard CTP maps (κ = 1 vs. κ = .6). rTmax was 82% (95%CI = 67–97%) accurate in predicting NCSE versus stroke in the hyperacute setting. Agreement between neuroimaging and electroencephalography (EEG) was limited at a hemispheric level for standard CTP maps, whereas rTMax had agreement with EEG largely reaching the sublobar level. SIGNIFICANCE: rTmax mapping might represent a reliable tool to spot NCSE‐induced hyperperfusion with a threshold‐based reproducible approach. Further studies are needed for validation and implementation in the differential diagnosis of focal neurological deficit in the hyperacute setting. John Wiley and Sons Inc. 2022-07-20 2022-10 /pmc/articles/PMC9796764/ /pubmed/35793391 http://dx.doi.org/10.1111/epi.17359 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Article
Romoli, Michele
Merli, Elena
Galluzzo, Simone
Muccioli, Lorenzo
Testoni, Stefania
Zaniboni, Anna
Contardi, Sara
Simonetti, Luigi
Tinuper, Paolo
Zini, Andrea
Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title_full Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title_fullStr Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title_full_unstemmed Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title_short Hyperperfusion Tmax mapping for nonconvulsive status epilepticus in the acute setting: A pilot case–control study
title_sort hyperperfusion tmax mapping for nonconvulsive status epilepticus in the acute setting: a pilot case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796764/
https://www.ncbi.nlm.nih.gov/pubmed/35793391
http://dx.doi.org/10.1111/epi.17359
work_keys_str_mv AT romolimichele hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT merlielena hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT galluzzosimone hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT mucciolilorenzo hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT testonistefania hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT zanibonianna hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT contardisara hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT simonettiluigi hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT tinuperpaolo hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy
AT ziniandrea hyperperfusiontmaxmappingfornonconvulsivestatusepilepticusintheacutesettingapilotcasecontrolstudy